Polyomavirus Nephropathy: A Current Perspective and Clinical Considerations

American Journal of Kidney Diseases

Volumn 54, Issue 1, 2009, Pages 131-142

  Wiseman, Alexander C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

BK virus; kidney transplantation; Polyomavirus; review

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CIDOFOVIR; CIPROFLOXACIN; CORTICOSTEROID; CYCLOSPORIN A; HLA ANTIGEN; HLA C ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RAPAMYCIN; TACROLIMUS; VIRUS ANTIBODY; VIRUS DNA; VIRUS RNA;

ACUTE GRAFT REJECTION; AGING; ANTIVIRAL THERAPY; BK VIRUS; CADAVER DONOR; CLINICAL DECISION MAKING; CLINICAL FEATURE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; COST EFFECTIVENESS ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG URINE LEVEL; DRUG WITHDRAWAL; ELECTRON MICROSCOPY; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HISTOPATHOLOGY; HLA MATCHING; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INTERSTITIAL NEPHRITIS; JC VIRUS; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LIVING DONOR; LOADING DRUG DOSE; LOW DRUG DOSE; LUNG TRANSPLANTATION; MAINTENANCE THERAPY; PAPANICOLAOU TEST; PATHOGENESIS; PATIENT MONITORING; POLYMERASE CHAIN REACTION; POLYOMA VIRUS; PREVALENCE; RETRANSPLANTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SCREENING TEST; SERODIAGNOSIS; SEX RATIO; TREATMENT DURATION; URINALYSIS; VIREMIA; VIRUS REACTIVATION; VIRUS SHEDDING;

BK VIRUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; NEPHRITIS, INTERSTITIAL; POLYOMAVIRUS INFECTIONS; RISK FACTORS; TUMOR VIRUS INFECTIONS;

EID: 67449143210     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.01.271     Document Type: Review

References (99)

1. Gardner S.D., Field A.M., Coleman D.V., and Hulme B. New human papovavirus (BK) isolated from urine after renal transplantation. Lancet 1 (1971) 1253-1257
2. Purighalla R., Shapiro R., McCauley J., and Randhawa P. BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis 26 (1995) 671-673
3. Randhawa P.S., Finkelstein S., Scantlebury V., et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 67 (1999) 103-109
4. Binet I., Nickeleit V., Hirsch H.H., et al. Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss. Transplantation 67 (1999) 918-922
5. Hirsch H.H., Knowles W., Dickenmann M., et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 347 (2002) 488-496
6. Feng H., Shuda M., Chang Y., and Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319 (2008) 1096-1100
7. Stolt A., Sasnauskas K., Koskela P., Lehtinen M., and Dillner J. Seroepidemiology of the human polyomaviruses. J Gen Virol 84 (2003) 1499-1504
8. Neff R.T., Hurst F.P., Falta E.M., et al. Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. Transplantation 86 (2008) 1474-1478
9. Hogan T.F., Borden E.C., McBain J.A., Padgett B.L., and Walker D.L. Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med 92 (1980) 373-378
10. Erard V., Storer B., Corey L., et al. BK virus infection in hematopoietic stem cell transplant recipients: Frequency, risk factors, and association with postengraftment hemorrhagic cystitis. Clin Infect Dis 39 (2004) 1861-1865
11. Brennan D.C., Agha I., Bohl D.L., et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 5 (2005) 582-594
12. Bressollette-Bodin C., Coste-Burel M., Hourmant M., Sebille V., Andre-Garnier E., and Imbert-Marcille B.M. A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am J Transplant 5 (2005) 1926-1933
13. Nickeleit V., Klimkait T., Binet I.F., et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 342 (2000) 1309-1315
14. Ding R., Medeiros M., Dadhania D., et al. Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation 74 (2002) 987-994
15. Nickeleit V., Hirsch H.H., Binet I.F., et al. Polyomavirus infection of renal allograft recipients: From latent infection to manifest disease. J Am Soc Nephrol 10 (1999) 1080-1089
16. Hirsch H.H. Polyomavirus BK nephropathy: A (re-)emerging complication in renal transplantation. Am J Transplant 2 (2002) 25-30
17. Randhawa P., Ho A., Shapiro R., et al. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol 42 (2004) 1176-1180
18. Hymes L.C., and Warshaw B.L. Polyomavirus (BK) in pediatric renal transplants: Evaluation of viremic patients with and without BK associated nephritis. Pediatr Transplant 10 (2006) 920-922
19. Hirsch H.H., Brennan D.C., Drachenberg C.B., et al. Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 79 (2005) 1277-1286
20. Drachenberg C.B., Papadimitriou J.C., and Ramos E. Histologic versus molecular diagnosis of BK polyomavirus-associated nephropathy: A shifting paradigm?. Clin J Am Soc Nephrol 1 (2006) 374-379
21. Viscount H.B., Eid A.J., Espy M.J., et al. Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation 84 (2007) 340-345
22. Hoffman N.G., Cook L., Atienza E.E., Limaye A.P., and Jerome K.R. Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays. J Clin Microbiol 46 (2008) 2671-2680
23. Drachenberg C.B., Papadimitriou J.C., Hirsch H.H., et al. Histological patterns of polyomavirus nephropathy: Correlation with graft outcome and viral load. Am J Transplant 4 (2004) 2082-2092
24. Chan G.S., Tsoi H.W., Wong S.S., et al. BK virus nephropathy due to KOM-3 strain. Am J Kidney Dis 54 (2009) 122-126
25. Drachenberg C.B., Hirsch H.H., Papadimitriou J.C., et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: A prospective evaluation. Transplantation 84 (2007) 323-330
26. Randhawa P., Baksh F., Aoki N., Tschirhart D., and Finkelstein S. JC virus infection in allograft kidneys: Analysis by polymerase chain reaction and immunohistochemistry. Transplantation 71 (2001) 1300-1303
27. Kazory A., Ducloux D., Chalopin J.M., Angonin R., Fontaniere B., and Moret H. The first case of JC virus allograft nephropathy. Transplantation 76 (2003) 1653-1655
28. Wen M.C., Wang C.L., Wang M., et al. Association of JC virus with tubulointerstitial nephritis in a renal allograft recipient. J Med Virol 72 (2004) 675-678
29. Polo C., Perez J.L., Mielnichuck A., Fedele C.G., Niubo J., and Tenorio A. Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children. Clin Microbiol Infect 10 (2004) 640-644
30. Eash S., Manley K., Gasparovic M., Querbes W., and Atwood W.J. The human polyomaviruses. Cell Mol Life Sci 63 (2006) 865-876
31. Mengel M., Marwedel M., Radermacher J., et al. Incidence of polyomavirus-nephropathy in renal allografts: Influence of modern immunosuppressive drugs. Nephrol Dial Transplant 18 (2003) 1190-1196
32. Mannon R.B., Hoffmann S.C., Kampen R.L., et al. Molecular evaluation of BK polyomavirus nephropathy. Am J Transplant 5 (2005) 2883-2893
33. Lipshutz G.S., Flechner S.M., Govani M.V., and Vincenti F. BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen. Am J Transplant 4 (2004) 2132-2134
34. Randhawa P.S., Gupta G., Vats A., Shapiro R., and Viscidi R.P. Immunoglobulin G, A, and M responses to BK virus in renal transplantation. Clin Vaccine Immunol 13 (2006) 1057-1063
35. Awadalla Y., Randhawa P., Ruppert K., Zeevi A., and Duquesnoy R.J. HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. Am J Transplant 4 (2004) 1691-1696
36. Smith J.M., Dharnidharka V.R., Talley L., Martz K., and McDonald R.A. BK virus nephropathy in pediatric renal transplant recipients: An analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Clin J Am Soc Nephrol 2 (2007) 1037-1042
37. Ramos E., Drachenberg C.B., Papadimitriou J.C., et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 13 (2002) 2145-2151
38. Vasudev B., Hariharan S., Hussain S.A., Zhu Y.R., Bresnahan B.A., and Cohen E.P. BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients. Kidney Int 68 (2005) 1834-1839
39. Bohl D.L., Storch G.A., Ryschkewitsch C., et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant 5 (2005) 2213-2221
40. Ginevri F., Azzi A., Hirsch H.H., et al. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 7 (2007) 2727-2735
41. Bohl D.L., Brennan D.C., Ryschkewitsch C., Gaudreault-Keener M., Major E.O., and Storch G.A. BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol 43 (2008) 184-189
42. Hariharan S., Cohen E.P., Vasudev B., et al. BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis. Am J Transplant 5 (2005) 2719-2724
43. Randhawa P., Bohl D., Brennan D., et al. Longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients. Clin Vaccine Immunol 15 (2008) 1564-1571
44. Krymskaya L., Sharma M.C., Martinez J., et al. Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides. J Virol 79 (2005) 11170-11178
45. Binggeli S., Egli A., Schaub S., et al. Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients. Am J Transplant 7 (2007) 1131-1139
46. Comoli P., Azzi A., Maccario R., et al. Polyomavirus BK-specific immunity after kidney transplantation. Transplantation 78 (2004) 1229-1232
47. Comoli P., Binggeli S., Ginevri F., and Hirsch H.H. Polyomavirus-associated nephropathy: update on BK virus-specific immunity. Transpl Infect Dis 8 (2006) 86-94
48. Benavides C.A., Pollard V.B., Mauiyyedi S., Podder H., Knight R., and Kahan B.D. BK virus-associated nephropathy in sirolimus-treated renal transplant patients: Incidence, course, and clinical outcomes. Transplantation 84 (2007) 83-88
49. Wadei H.M., Rule A.D., Lewin M., et al. Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant 6 (2006) 1025-1032
50. Weiss A.S., Gralla J., Chan L., Klem P., and Wiseman A.C. Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: A comparison of two reduction strategies. Clin J Am Soc Nephrol 3 (2008) 1812-1819
51. Wali R.K., Drachenberg C., Hirsch H.H., et al. BK virus-associated nephropathy in renal allograft recipients: Rescue therapy by sirolimus-based immunosuppression. Transplantation 78 (2004) 1069-1073
52. Womer K.L., Guerra G., Dibadj K., et al. Immunosuppression reduction for BK virus nephropathy: A case for caution. Transpl Infect Dis 9 (2007) 244-248
53. Ramos E., Drachenberg C.B., Portocarrero M., et al. BK virus nephropathy diagnosis and treatment: Experience at the University of Maryland Renal Transplant Program. Clin Transpl (2002) 143-153
54. McGilvray I.D., Lajoie G., Humar A., and Cattral M.S. Polyomavirus infection and acute vascular rejection in a kidney allograft: Coincidence or mimicry?. Am J Transplant 3 (2003) 501-504
55. Drachenberg C.B., and Papadimitriou J.C. Polyomavirus-associated nephropathy: Update in diagnosis. Transpl Infect Dis 8 (2006) 68-75
56. Hussain S., Bresnahan B.A., Cohen E.P., and Hariharan S. Rapid kidney allograft failure in patients with polyoma virus nephritis with prior treatment with antilymphocyte agents. Clin Transplant 16 (2002) 43-47
57. Jahnukainen T., Malehorn D., Sun M., et al. Proteomic analysis of urine in kidney transplant patients with BK virus nephropathy. J Am Soc Nephrol 17 (2006) 3248-3256
58. Celik B., Shapiro R., Vats A., and Randhawa P.S. Polyomavirus allograft nephropathy: Sequential assessment of histologic viral load, tubulitis, and graft function following changes in immunosuppression. Am J Transplant 3 (2003) 1378-1382
59. Howell D.N., Smith S.R., Butterly D.W., et al. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients. Transplantation 68 (1999) 1279-1288
60. Funk G.A., Steiger J., and Hirsch H.H. Rapid dynamics of polyomavirus type BK in renal transplant recipients. J Infect Dis 193 (2006) 80-87
61. Farasati N.A., Shapiro R., Vats A., and Randhawa P. Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation 79 (2005) 116-118
62. De Clercq E. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin Microbiol Rev 16 (2003) 569-596
63. Bernhoff E., Gutteberg T.J., Sandvik K., Hirsch H.H., and Rinaldo C.H. Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression. Am J Transplant 8 (2008) 1413-1422
64. Kuypers D.R., Vandooren A.K., Lerut E., et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 5 (2005) 1997-2004
65. Josephson M.A., Gillen D., Javaid B., et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 81 (2006) 704-710
66. Faguer S., Hirsch H.H., Kamar N., et al. Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation. Transpl Int 20 (2007) 962-969
67. Leca N., Muczynski K.A., Jefferson J.A., et al. Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients. Clin J Am Soc Nephrol 3 (2008) 829-835
68. Randhawa P.S. Anti-BK virus activity of ciprofloxacin and related antibiotics. Clin Infect Dis 41 (2005) 1366-1367 author reply, 1367
69. Leung A.Y., Chan M.T., Yuen K.Y., et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 40 (2005) 528-537
70. Kazatchkine M.D., and Kaveri S.V. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345 (2001) 747-755
71. Sener A., House A.A., Jevnikar A.M., et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: One-year follow-up of renal allograft recipients. Transplantation 81 (2006) 117-120
72. Sharma A.P., Moussa M., Casier S., Rehman F., Filler G., and Grimmer J. Intravenous immunoglobulin as rescue therapy for BK virus nephropathy. Pediatr Transplant 13 (2009) 123-129
73. Ortiz A., Justo P., Sanz A., et al. Tubular cell apoptosis and cidofovir-induced acute renal failure. Antivir Ther 10 (2005) 185-190
74. Bollee G., Anglicheau D., Loupy A., et al. High-dosage intravenous immunoglobulin-associated macrovacuoles are associated with chronic tubulointerstitial lesion worsening in renal transplant recipients. Clin J Am Soc Nephrol 3 (2008) 1461-1468
75. Vo A.A., Cam V., Toyoda M., et al. Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: A single-center experience. Clin J Am Soc Nephrol 1 (2006) 844-852
76. Randhawa P., and Brennan D.C. BK virus infection in transplant recipients: An overview and update. Am J Transplant 6 (2006) 2000-2005
77. Bansal S., Lucia M.S., and Wiseman A. A case of polyomavirus-associated nephropathy presenting late after transplantation. Nat Clin Pract Nephrol 4 (2008) 283-287
78. Saad E.R., Bresnahan B.A., Cohen E.P., et al. Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. Transplantation 85 (2008) 850-854
79. Almeras C., Foulongne V., Garrigue V., et al. Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients?. A prospective study. Transplantation 85 (2008) 1099-1104
80. Kiberd B.A. Screening to prevent polyoma virus nephropathy: A medical decision analysis. Am J Transplant 5 (2005) 2410-2416
81. Sukov W.R., Lewin M., Sethi S., Rakowski T.A., and Lager D.J. BK virus-associated nephropathy in a patient with AIDS. Am J Kidney Dis 51 (2008) e15-e18
82. Maddirala S., Pitha J.V., Cowley Jr. B.D., and Haragsim L. End-stage renal disease due to polyomavirus in a cardiac transplant patient. Nat Clin Pract Nephrol 3 (2007) 393-396
83. Barber C.E., Hewlett T.J., Geldenhuys L., Kiberd B.A., Acott P.D., and Hatchette T.F. BK virus nephropathy in a heart transplant recipient: Case report and review of the literature. Transpl Infect Dis 8 (2006) 113-121
84. Limaye A.P., Smith K.D., Cook L., et al. Polyomavirus nephropathy in native kidneys of non-renal transplant recipients. Am J Transplant 5 (2005) 614-620
85. Menahem S.A., McDougall K.M., Thomson N.M., and Dowling J.P. Native kidney BK nephropathy post cardiac transplantation. Transplantation 79 (2005) 259-260
86. Doucette K.E., Pang X.L., Jackson K., et al. Prospective monitoring of BK polyomavirus infection early posttransplantation in nonrenal solid organ transplant recipients. Transplantation 85 (2008) 1733-1736
87. Thomas L.D., Vilchez R.A., White Z.S., et al. A prospective longitudinal study of polyomavirus shedding in lung-transplant recipients. J Infect Dis 195 (2007) 442-449
88. Barton T.D., Blumberg E.A., Doyle A., et al. A prospective cross-sectional study of BK virus infection in non-renal solid organ transplant recipients with chronic renal dysfunction. Transpl Infect Dis 8 (2006) 102-107
89. Atencio I.A., Shadan F.F., Zhou X.J., Vaziri N.D., and Villarreal L.P. Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration. J Virol 67 (1993) 1424-1432
90. Fishman J.A. BK virus nephropathy-Polyomavirus adding insult to injury. N Engl J Med 347 (2002) 527-530
91. Bogdanovic G., Priftakis P., Giraud G., et al. Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation. J Clin Microbiol 42 (2004) 5394-5396
92. Poduval R.D., Meehan S.M., Woodle E.S., et al. Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis. Transplantation 73 (2002) 1166-1169
93. Ginevri F., Pastorino N., de Santis R., et al. Retransplantation after kidney graft loss due to polyoma BK virus nephropathy: Successful outcome without original allograft nephrectomy. Am J Kidney Dis 42 (2003) 821-825
94. Ramos E., Vincenti F., Lu W.X., et al. Retransplantation in patients with graft loss caused by polyoma virus nephropathy. Transplantation 77 (2004) 131-133
95. Al-Jedai A.H., Honaker M.R., Trofe J., et al. Renal allograft loss as the result of polyomavirus interstitial nephritis after simultaneous kidney-pancreas transplantation: results with kidney retransplantation. Transplantation 75 (2003) 490-494
96. Poduval R.D., Meehan S.M., Woodle E.S., et al. Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis. Transplantation 73 (2002) 1166-1169
97. Hirsch H.H., and Ramos E. Retransplantation after polyomavirus-associated nephropathy: just do it?. Am J Transplant 6 (2006) 7-9
98. Womer K.L., Meier-Kriesche H.U., Patton P.R., et al. Preemptive retransplantation for BK virus nephropathy: Successful outcome despite active viremia. Am J Transplant 6 (2006) 209-213
99. Hirsch H.H., and Steiger J. Polyomavirus BK. Lancet Infect Dis 3 (2003) 611-623